Globe Life stock barely flinched after Q3 2026 earnings, slipping about 0.7% to US$168.41 even as the insurer posted basic earnings per share of US$4.71 and net income of US$361.1m. Short-term traders see a quiet tape. Longer term investors see a different story, centred on a company with a trailing P/E of 10.9 that sits well below a peer average of 39.2 and a model valuation that suggests the shares trade at a steep discount.
If you like Globe Life’s valuation profile and are looking for more peers that combine compressed P/E ratios with resilient fundamentals and clean balance sheets, take a look at our list of solid balance sheet and fundamentals stocks (26 results).